Stephen D. Wiviott
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management 28
- Cardiology and Cardiovascular Medicine top 0.01%
- Antiplatelet Therapy and Cardiovascular Diseases 102
- Acute Myocardial Infarction Research 99
- Atrial Fibrillation Management and Outcomes 31
- Heart Failure Treatment and Management 23
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes Treatment and Management 25
- Surgery top 0.01%
- Lipoproteins and Cardiovascular Health 44
- Coronary Interventions and Diagnostics 42
- Nephrology top 0.5%
- Co-authors
- Sabina A. MurphyEugene BraunwaldElliott M. AntmanMarc S. SabatineDeepak L. BhattCarolyn H. McCabeC. Michael GibsonLawrence A. Leiter
- Cited by
- Internal MedicineCardiology and Cardiovascular MedicineEndocrinology, Diabetes and Metabolism
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Stephen D. Wiviott
198 papers receiving 36.6k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Internal Medicine 4.9k
- Cardiology and Cardiovascular Medicine 23.1k
- Endocrinology, Diabetes and Metabolism 12.1k
- Surgery 17.8k
- Nephrology 1.2k
Countries citing papers authored by Stephen D. Wiviott
This map shows the geographic impact of Stephen D. Wiviott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Wiviott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Wiviott more than expected).
Fields of papers citing papers by Stephen D. Wiviott
This network shows the impact of papers produced by Stephen D. Wiviott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Wiviott. The network helps show where Stephen D. Wiviott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen D. Wiviott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 0 | |
| 5 | 2020 | 3 | |
| 6 | Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitusbreakdown → | 2019 | 534 |
| 7 | Abstract 15670: Relationship Between Baseline Cardiac Biomarkers and Cardiovascular Death or Hospitalization for Heart Failure in DECLARE-TIMI 58 | 2019 | 2 |
| 8 | 2017 | 82 | |
| 9 | 2017 | 39 | |
| 10 | 2012 | 4 | |
| 11 | 2010 | 321 | |
| 12 | 2010 | 70 | |
| 13 | Abstract 2126: CYP2C19 Genetic Variants and Clinical Outcomes With Clopidogrel: A Collaborative Meta-Analysis | 2009 | 12 |
| 14 | 2009 | 193 | |
| 15 | Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38breakdown → | 2008 | 498 |
| 16 | Abstract 3994: Pharmacodynamic Assessment of Platelet Inhibition by Prasugrel versus Clopidogrel in the TRITON-TIMI 38 Trial | 2008 | 2 |
| 17 | 2008 | 325 | |
| 18 | Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromesbreakdown → | 2007 | 4421 |
| 19 | 2004 | 74 | |
| 20 | 1992 | 32 |
About Stephen D. Wiviott
Stephen D. Wiviott is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, having authored 206 papers that have together received 37.8k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (102 papers), Acute Myocardial Infarction Research (99 papers), Lipoproteins and Cardiovascular Health (44 papers), Coronary Interventions and Diagnostics (42 papers), Atrial Fibrillation Management and Outcomes (31 papers), Venous Thromboembolism Diagnosis and Management (28 papers), Diabetes Treatment and Management (25 papers) and Heart Failure Treatment and Management (23 papers). The work is most often cited by research in Internal Medicine (4.9k citations), Cardiology and Cardiovascular Medicine (23.1k citations) and Endocrinology, Diabetes and Metabolism (12.1k citations). Stephen D. Wiviott has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Sabina A. Murphy, Eugene Braunwald, Elliott M. Antman, Marc S. Sabatine, Deepak L. Bhatt, Carolyn H. McCabe, C. Michael Gibson, Lawrence A. Leiter, Robert P. Giugliano and Darren K. McGuire. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.